Journal
HEALTH AFFAIRS
Volume 29, Issue 10, Pages 1812-1817Publisher
PROJECT HOPE
DOI: 10.1377/hlthaff.2010.0692
Keywords
-
Funding
- National Pharmaceutical Council
Ask authors/readers for more resources
The Patient Protection and Affordable Care Act established a new Patient-Centered Outcomes Research Institute to identify and address research priorities for comparative effectiveness research. Among its many responsibilities, the institute has been charged with setting priorities, developing methodological standards, and communicating research results to decision makers. In this paper we consider how the institute can support the different standards for acceptable evidence used by various government agencies, providers, patients, and other decision makers. We argue that the public interest will best be served if the institute develops a balanced and flexible approach to deciding which types of studies to fund.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available